CHENGDU, China, June 6, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", 6990.HK) today announced that results from its registrational study (OptiTROP-Lung03) evaluating sacituzumab tirumotecan (sac-TMT) versus docetaxel in patients with previously...
Hence then, the article about the british medical journal publishes study results on sacituzumab tirumotecan for previously treated egfr mutant advanced nsclc was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC )
Also on site :
- Child Psychologists Are Begging Parents and Grandparents To Stop Asking Kids This Question (and What To Ask Instead)
- Ousted L3Harris CEO Chris Kubasik forfeits $45 million—but he’ll still walk away with $80 million in stock and options
- ‘Dancing with the Stars: The Next Pro’: Witney Carson Arrives to Judge a Brutal Coaching Challenge — See Who Went Home